Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Sanofi”
Sponsor: Sanofi
Sickle Cell Disease
United States, Belgium, Brazil, France, Germany +8 more
Sponsor: Sanofi
Respiratory Syncytial Virus Immunization · Human Metapneumovirus Immunization · Healthy Volunteers
United States
Sponsor: Sanofi
Non-cystic Fibrosis Bronchiectasis
United States
- Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia AActive Not Recruiting
Sponsor: Bioverativ, a Sanofi company
Hemophilia A
United States, Argentina, Australia, Belgium, Brazil +18 more
Sponsor: Sanofi
Atopic Dermatitis
Qatar, Saudi Arabia, United Arab Emirates
- ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening ProgramEnrolling By Invitation
Sponsor: Albert Einstein College of Medicine
Acid Sphingomyelinase Deficiency · Ceroid Lipofuscinosis, Neuronal, 2 · Cerebrotendinous Xanthomatosis · Fabry Disease
United States
Sponsor: Sanofi
Immunoglobulin G4 Related Disease
United States, Argentina, Belgium, Canada, Chile +14 more
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections
Mozambique, South Africa, Zimbabwe
- Study to Compare the Plasma Concentration of Belumosudil Given as an Oral Suspension and as a Tablet to Healthy Adult Male ParticipantsNot Yet Recruiting
Sponsor: Sanofi
Chronic Graft Versus Host Disease
Sponsor: Sanofi
Polyneuropathy, Inflammatory Demyelinating, Chronic
United States
Sponsor: Centers for Disease Control and Prevention
Latent Tuberculosis
South Africa
- Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and LymphomaActive Not Recruiting
Sponsor: Divaya Bhutani
Lymphoma · Multiple Myeloma · Non-Hodgkin Lymphoma · Relapsed Hodgkin's Disease, Adult
United States
- Isatuximab in Patients With Monoclonal Gammopathy of Renal SignificanceActive Not Recruiting
Sponsor: Columbia University
Monoclonal Gammopathy
United States
Sponsor: M.D. Anderson Cancer Center
Phase 1 · SAR445877 · FOlfox6 · Bevacizimab
United States
- Intrahospital Influenza Vaccination in Patients at High Cardiovascular Risk (VACC-UP)Not Yet Recruiting
Sponsor: Stephan Baldus
Acute Coronary Syndrome · Heart Failure · Influenza, Human · Cardiovascular Diseases
Germany
Sponsor: Sanofi
Dermatitis Atopic
United States, Argentina, Australia, Brazil, Canada +10 more
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Colorectal Neoplasms · Carcinoma, Non-Small-Cell Lung · Stomach Neoplasms · Pancreatic Ductal Adenocarcinoma
United States, Canada, China, France, Israel +5 more
Sponsor: Sanofi
Type 2 Diabetes Mellitus
Taiwan
- Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy ParticipantsActive Not Recruiting
Sponsor: Sanofi
Healthy Volunteers
United States
Sponsor: Sanofi
Gastric Cancer · Oesophageal Carcinoma
China
- Universal Type 1 Diabetes Screening in PediatricsNot Yet Recruiting
Sponsor: Northwestern University
Type 1 Diabetes (T1D)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
RSV Infection
United States
- Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple SclerosisActive Not Recruiting
Sponsor: Sanofi
Multiple Sclerosis
United States, Argentina, Austria, Belgium, Brazil +36 more
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Aplastic Anemia
China
Sponsor: Sanofi
Focal Segmental Glomerulosclerosis · Glomerulonephritis Minimal Lesion
United States, Argentina, Australia, Brazil, Canada +17 more